Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Agaran
- Development stage
- Unknown
- Lead developer
- Nippon Zoki Pharmaceutical
- Administration
- Oral
01
Overview
Agaran is an over-the-counter (OTC) herbal sedative tablet developed, manufactured, and marketed by Nippon Zoki Pharmaceutical in Japan. Approved as a Class 2 OTC drug, Agaran is formulated with a combination of five natural herbal extracts: valerian extract (kanokoso), passion flower extract (tokeisou), uncaria hook extract (choutoukou), hops extract, and ginseng extract (ninjin). It is indicated for calming nervous tension, excitement, and irritability, as well as alleviating associated fatigue, malaise, and headaches. Agaran is designed to relieve temporary anxiety and nervousness in stressful situations such as public speaking, exams, interviews, or recitals.
- Brand names
- Agaran
- Other names
- Agaran joAgaran tabletsアガラン
Beyond the preview
Go deeper on Agaran.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Agaran.